Total Payments
$16,765
2024 Payments
$2,821
Companies
61
Transactions
831
Medicare Patients
17,072
Medicare Billing
$986,623
Payment Breakdown by Category
Food & Beverage$16,042 (95.7%)
Consulting$540.00 (3.2%)
Education$183.00 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,042 | 827 | 95.7% |
| Consulting Fee | $540.00 | 1 | 3.2% |
| Education | $183.00 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,040 | 83 | $0 (2024) |
| Astellas Pharma US Inc | $1,343 | 64 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,209 | 65 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $1,146 | 81 | $0 (2024) |
| Janssen Biotech, Inc. | $1,088 | 70 | $0 (2024) |
| ABBVIE INC. | $929.94 | 52 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $864.55 | 41 | $0 (2024) |
| PFIZER INC. | $682.76 | 38 | $0 (2024) |
| UROGEN PHARMA, INC. | $638.35 | 29 | $0 (2024) |
| Blue Earth Diagnostics Limited | $590.92 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,821 | 122 | Sumitomo Pharma America, Inc. ($570.47) |
| 2023 | $2,683 | 108 | Dendreon Pharmaceuticals LLC ($479.01) |
| 2022 | $2,538 | 131 | Dendreon Pharmaceuticals LLC ($307.19) |
| 2021 | $2,536 | 150 | Bayer HealthCare Pharmaceuticals Inc. ($290.89) |
| 2020 | $1,233 | 66 | Dendreon Pharmaceuticals LLC ($241.81) |
| 2019 | $2,017 | 85 | Covidien LP ($540.00) |
| 2018 | $1,246 | 71 | Astellas Pharma US Inc ($273.85) |
| 2017 | $1,690 | 98 | PFIZER INC. ($183.82) |
All Payment Transactions
831 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: HORMONE THERAPY | ||||||
| 12/09/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 11/26/2024 | C. R. Bard, Inc. & Subsidiaries | — | Food and Beverage | In-kind items and services | $21.66 | General |
| 11/25/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: UROLOGY | ||||||
| 11/15/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: NONE | ||||||
| 11/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/13/2024 | PFIZER INC. | TALZENNA (Drug), XTANDI | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 10/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Oncology | ||||||
| 10/23/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 10/10/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 4,073 | 9,143 | $721,540 | $230,286 |
| 2022 | 26 | 4,263 | 13,429 | $820,673 | $241,878 |
| 2021 | 28 | 4,318 | 6,937 | $893,210 | $270,245 |
| 2020 | 36 | 4,418 | 15,538 | $934,911 | $244,214 |
Total Patients
17,072
Total Services
45,047
Medicare Billing
$986,623
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 818 | 1,384 | $332,160 | $126,846 | 38.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 95 | 116 | $52,200 | $21,271 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $53,655 | $17,026 | 31.7% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 18 | 19 | $35,739 | $8,565 | 24.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 261 | 354 | $28,320 | $7,911 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 130 | $21,650 | $7,826 | 36.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 353 | 420 | $24,360 | $7,514 | 30.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 453 | 581 | $70,855 | $4,576 | 6.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 431 | 541 | $6,492 | $4,536 | 69.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 36 | 36 | $14,400 | $3,606 | 25.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $18,700 | $3,556 | 19.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 641 | 941 | $7,528 | $3,194 | 42.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 400 | 564 | $8,460 | $2,222 | 26.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 22 | 31 | $11,005 | $1,894 | 17.2% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 20 | 767 | $3,068 | $1,620 | 52.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 24 | 25 | $6,375 | $1,505 | 23.6% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 46 | 59 | $4,366 | $1,492 | 34.2% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 28 | 31 | $6,665 | $1,458 | 21.9% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 39 | 56 | $3,680 | $1,086 | 29.5% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 11 | 11 | $6,292 | $1,044 | 16.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 35 | 35 | $2,450 | $896.70 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 46 | $2,530 | $507.60 | 20.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 13 | $364.00 | $65.91 | 18.1% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 11 | 2,825 | $226.00 | $65.75 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 824 | 1,403 | $336,720 | $128,829 | 38.3% |
About Dr. Robert Brown, M.D
Dr. Robert Brown, M.D is a Urology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609830165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Brown, M.D has received a total of $16,765 in payments from pharmaceutical and medical device companies, with $2,821 received in 2024. These payments were reported across 831 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($16,042).
As a Medicare-enrolled provider, Brown has provided services to 17,072 Medicare beneficiaries, totaling 45,047 services with total Medicare billing of $986,623. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Richmond, VA
- Active Since 04/13/2006
- Last Updated 10/28/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1609830165
Products in Payments
- PROVENGE (Drug) $2,203
- XIAFLEX (Biological) $1,060
- GEMTESA (Drug) $968.23
- XTANDI (Drug) $921.70
- Nubeqa (Drug) $751.57
- JELMYTO (Drug) $638.35
- ERLEADA (Drug) $625.58
- LigaSure (Device) $540.00
- Prolia (Biological) $509.57
- Axumin (Drug) $485.20
- LUPRON DEPOT (Drug) $466.84
- Xofigo (Drug) $457.09
- Xtandi (Drug) $392.38
- ORGOVYX (Drug) $387.97
- PYLARIFY (Drug) $365.44
- AVEED (Biological) $334.71
- PLUVICTO (Drug) $308.37
- BOTOX (Biological) $297.21
- Dornier MedTech (Device) $289.20
- Erleada (Drug) $283.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Richmond
Dr. Anthony Sliwinski, M.d, M.D
Urology — Payments: $76,833
Urology $76,833
Dr. Lonny Green, M.d, M.D
Urology — Payments: $65,404
Urology $65,404
Dr. John Delisio, M.d, M.D
Urology — Payments: $38,212
Urology $38,212
Dr. Eugene Kramolowsky, M.d, M.D
Urology — Payments: $30,695
Urology $30,695
Dr. Charles Seabury, M.d, M.D
Urology — Payments: $27,026
Urology $27,026
Dr. Michael Franks, Md, MD
Urology — Payments: $24,609
Urology $24,609